Investment Summary |
|
|---|---|
| Date | 2024-12-13 |
| Target | Nimble Therapeutics |
| Sector | Life Science |
| Investor(s) | AbbVie |
| Sellers(s) | Telegraph Hill Partners |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2012 |
| Sector | Life Science |
| Employees | 55,000 |
| Revenue | 56.3B USD (2024) |
AbbVie is a research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address complex and serious diseases. AbbVie's products are focused on treating conditions such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis, and Crohn's disease; low testosterone; HIV; endometriosis; thyroid disease; Parkinson's disease; and complications associated with chronic kidney disease and cystic fibrosis, among other health conditions. AbbVie was founded in 2012 and is based in North Chicago, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 13 of 15 |
| Sector: Life Science M&A | 13 of 15 |
| Type: Add-on Acquisition M&A Deals | 12 of 13 |
| State: Wisconsin M&A | 1 of 1 |
| Country: United States M&A | 11 of 13 |
| Year: 2024 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-10-28 |
Aliada Therapeutics
Boston, Massachusetts, United States Aliada Therapeutics is a biotechnology company focused on addressing delivery challenges in CNS drug development. Aliada Therapeutics is based in Boston, Massachusetts. |
Buy | $1.4B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-06-30 |
Capstan
San Diego, California, United States Capstan Therapeutics is developing a targeted delivery platform and therapeutics to reprogram immune cells in vivo for a broad range of disease categories. Capstan was founded in 2021 and is based in San Diego, California. |
Buy | $2.1B |
| Category | Venture Capital Firm |
|---|---|
| Founded | 2001 |
| Size | Middle-Market |
| Type | Sector Focused |
Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 29 of 29 |
| Sector: Life Science M&A | 13 of 13 |
| Type: Add-on Acquisition M&A Deals | 24 of 24 |
| State: Wisconsin M&A | 2 of 2 |
| Country: United States M&A | 28 of 28 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-02-07 |
n6
Pleasanton, California, United States n6 is a developer of advanced thermocycling technology for DNA amplification and sequencing. n6 is based in Pleasanton, California. |
Buy | - |
